|
Asthma Supplement to the National Ambulatory Medical Care Survey (NAMCS)
|
Health Survey
|
CDC
|
NHLBI, NIAID, NICHD, NIEHS
|
The National Ambulatory Medical Care Survey (NAMCS) Asthma Supplement is a national survey of physician''s opinions about and use of the National Asthma Education and Prevention Program (NAEPP) Guidelines for the Diagnosis and Management of Asthma. The National Institutes of Health and the National Center for Health Statistics collaborate on this activity.
|
|
ASTM International F-2529-13--Standard Guide for In-Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM)
|
Research Initiative
|
FDA
|
NIDCR
|
Provide a guide based on consensus of viewpoints used to determine the osteoinductive potential of a DBM containing products utilizing the arthymic rodent model.
|
|
Auditory (Hearing) Screening Supplement for Early Childhood Longitudinal Study
|
Health Survey
|
CDC
|
NIDCD
|
The objective of this Inter-Agency Agreement is to implement a hearing examination protocol in the Early Childhood Longitudinal Study of the Kindergarten Class of 2010–11. This is a large (n=20,000), nationally representative school-based exam and interview survey sponsored by the National Center for Education Statistics (NCES), U.S. Department of Education. The last NCES longitudinal cohort study of school age children began with the 1998 Kindergarten Class. In this earlier cohort, there were no hearing exams (nor vision exams) and the number of young children with hearing loss (reported by parents or teachers) shrank considerably after the initial enrollment of Kindergarteners. In the U.S., the last comprehensive national study of children with hearing exam measures was the 1963–1965 National Health Examination Survey (NHES, i.e., the predecessor of NHANES) for children aged 6 to 11 years. A randomly selected sub-sample of about 4500 children were identified for more frequent follow-up and these children have also been selected for the hearing examination; they are also included in a “selected” (protected) subsample for more intensive tracking in follow-up waves of the survey. Children in the selected subsample will be tracked to new schools when possible if they are later enrolled in (moved to) a school that was not in the original school sample, e.g., when families relocate. In addition to hearing, the ECLS-K: 2010-11 will track several other outcome measures (e.g., general health, social and physical development, achievement scores, and parental and teacher-reported communication problems) associated with educational performance. Hearing will be tested when the children are examined with achievement testing in the school setting. NCES has awarded a contract to WESTAT to conduct the field operations, including selection of sample schools, data collection, and preparation of user-friendly research data files. The contractor will obtain longitudinal measures of hearing sensitivity and middle ear function of Kindergartners during the fall of Second grade (calendar year 2012), spring of Third grade (calendar year 2014), and spring of Fifth grade (calendar year 2016). Hearing thresholds will be recorded from each ear separately. In addition, the contractor will obtain tympanometric traces to assess middle ear function and, also, wideband reflectometry beginning in the spring of Third grade to improve classification of sensorineural versus conductive hearing loss.
|
|
Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
OD/OSP, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
The purpose of the ADCC is to provide a forum for the coordination of research efforts in autoimmunity and autoimmune diseases among various stakeholders including the NIH, other federal agencies such as the FDA and the CDC, and private organizations with an interest in autoimmune diseases. The ADCC meets twice yearly to discuss a broad range of basic, preclinical and clinical endeavors.
|
|
B-24 Project
|
Research Initiative
|
CDC, FDA
|
NICHD
|
NICHD has played a lead role in the evolution of the process to include infants/children from birth to 24 months and pregnant women in future (2020 and beyond) iterations of the Dietary Guidelines for Americans; the "B-24 Project." An offshoot of that project was the effort to develop guidelines for nutritional care of preterm infants (the "Pre-B Project"). Both projects have included members of the CDC and FDA on working groups constituted to develop the initial reports that will serve as the basis for the subsequent systematic review and guideline development process.
|
|
Behavioral Aspects of Prep Counseling HIV Prevention Trials Network (HPTN) Protocol #067: The ADAPT Study (Y01-MH-0315)
|
Research Initiative
|
CDC
|
NIMH, NIAID
|
This behavioral research study is evaluating whether non-daily medication regimens for HIV Pre-Exposure Prophylaxis (PrEP) may be more acceptable and foster better adherence to treatment. PrEP represents a novel biomedical approach to HIV prevention in which individuals at-risk for HIV take antiretroviral medications to help prevent HIV infection. The HPTN 067 study is conducted through the NIAID-led HIV Prevention Trials Network. An interagency agreement between NIMH and CDC supports the implementation of this international research study at a clinical research site in Bangkok, Thailand.
|
|
Behavioral Health Coordinating Council (BHCC) Subcommittee on Marijuana
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, SAMHSA
|
NIDA
|
Behavioral Health Coordinating Council (BHCC) Subcommittee on Marijuana develops projects with clear goals, provides guidance to achieve steady progress and measurable outcomes, and develop key policy messages on issues related to marijuana
|
|
Behavioral Health Coordinating Council (BHCC) Subcommittee On Primary Care And Behavioral Health Integration
|
Committee, Work group, Advisory group, or Task Force
|
ACL, AHRQ, CMS, HRSA, IHS, SAMHSA
|
NIDA, NIAAA, NIMH
|
Subcommittee of Behavioral Health Coordinating Council (BHCC) that collaborates on primary care and behavioral integration.
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The Best Pharmaceuticals for Children Act (BPCA) Data Coordinating Center (DCC) is responsible for managing all aspects of BPCA clinical trials including developing trial design, collecting and analyzing trial data, monitoring data quality, conducting site monitoring, collecting and preparing safety reports, organizing and submitting documentation to the FDA, and managing the Data Monitoring Committee.
|
|
Best Pharmaceuticals for Children Act Working Group (BPCA)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
This working group supports the goals of the Best Pharmaceuticals for Children Act (BPCA). The BPCA seeks to improve the level of information—in scientific publications and on the label—about pharmaceuticals used to treat children. The BPCA requires that the NIH identify the drugs of highest priority for study in pediatric populations and publish a list of drugs/needs in pediatric therapeutics.
|